Abstract:Key PointsTwo major classes of ubiquitin ligases, the SKP1–CUL1–F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), have a central role in cell-cycle regulation.The SCF complex and APC/C are structurally similar. Each is constituted of common subunits and a variable substrate-recognition subunit (F-box proteins for the SCF complex and activators for the APC/C). Three F-box proteins in the SCF complex — S-phase kinase-associated protein 2 (SKP2), F-box and WD-40 domain protein 7 (FBW7) and β-transducin repeat-containing protein (β-TRCP) — and two activators in the APC/C — cell division cycle 20 (CDC20) and CDH1 (also known as HCT1) — are the most important in cell-cycle regulation.SKP2 targets negative regulators of the cell cycle such as p27, p21 and p57 for degradation, and thereby promotes cell-cycle progression during S and G2 phases. SKP2 is upregulated in many human cancers.FBW7 induces the degradation of positive regulators of the cell cycle, such as MYC, JUN, cyclin E and Notch. FBW7 is often mutated in a subset of human cancers.β-TRCP is a versatile F-box protein that recognizes several cell-cycle regulators — EMI1/2, WEE1A and CDC25A/B — in addition to its classical substrates, β-catenin and IκB. In some cancers, β-TRCP mutation or overexpression is found.CDC20 targets securin and mitotic cyclins for destruction, and thereby promotes sister-chromatid separation. CDC20 is the crucial mediator of the spindle checkpoint, which prevents aneuploidy and genomic instability. CDC20 is overexpressed in some cancers, although in others the CDC20 gene is mutated or deleted.CDH1 facilitates exit from M phase and maintains G1 phase by mediating the degradation of mitotic cyclins, non-CDK (cyclin-dependent kinase) mitotic kinases and some regulators of the formation of pre-replicative complexes. Deregulated expression or mutation of CDH1 as well as of most CDH1 targets have been described in human cancers.

Ubiquitylation and Proteasomal Degradation of the P21cip1, P27kip1and P57kip2cdk Inhibitors

Ubiquitylation and Proteasomal Degradation of the P21(Cip1), P27(Kip1) and P57(Kip2) Cdk Inhibitors

Stabilization of p27 Kip1 /CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control.

CDK Inhibitors: Cell Cycle Regulators and Beyond

Structural Basis of the Cks1-Dependent Recognition of p27Kip1 by the SCFSkp2 Ubiquitin Ligase

Cks1: Structure, Emerging Roles and Implications in Multiple Cancers

New functional activities for the p21 family of CDK inhibitors.

Deubiquitylation And Stabilization Of P21 By Usp11 Is Critical For Cell-Cycle Progression And Dna Damage Responses

Inhibition of Cyclin-Dependent Kinases by P21.

P57(Kip2), A Structurally Distinct Member of the P21(Cip1) Cdk Inhibitor Family, is A Candidate Tumor-Suppressor Gene

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1

CK1δ Activity is Modulated by CDK2/E- and CDK5/p35-mediated Phosphorylation

Ubiquitin ligases: cell-cycle control and cancer

Regulation of SCF(SKP2) ubiquitin E3 ligase assembly and p27(KIP1) proteolysis by the PTEN pathway and cyclin D1.

p57Kip2 Phosphorylation Modulates Its Localization, Stability, and Interactions

A Novel Cycline/cyclina-Cdk Inhibitor Targets P27(kip1) Degradation, Cell Cycle Progression and Cell Survival: Implications in Cancer Therapy.

c-Jun NH2-terminal kinase decreases ubiquitination and promotes stabilization of p21WAF1/CIP1 in K562 cell

Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation

Dynamic anticipation by Cdk2/Cyclin A-bound p27 mediates signal integration in cell cycle regulation

PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2